Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Products>Product News
  Product News
STEMCELL Technologies Releases New MesenCult™ Proliferation Kit with MesenPure™
Saturday, May 17, 2014
A novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs).

Hologic’s New Tomcat Pre-analytical Sample Processing Instrument to be Featured at ASM2014
Thursday, May 15, 2014
The instrument streamlines laboratory workflow by providing automated processing of liquid-based cytology samples.

Improved Assays in Pain Research Using Native Neurons
Saturday, May 10, 2014
Cellectricon and Neusentis to present a webinar on May 16, from 11am EDT.

CDI Launches iCell® DopaNeurons, Neural Floor Plate-derived Midbrain Dopaminergic Neurons
Wednesday, April 30, 2014
Cells Provide a More Relevant In Vitro Model for Neurological Disorders, including Parkinson’s Disease and Schizophrenia.

American CryoStem Announces Breakthroughs in the Expansion and Lineage-Specific Differentiations of ADSCs
Monday, April 28, 2014
Company's ACS Laboratory division has completed its quarterly laboratory R&D program ahead of schedule, yielding new intellectual property and positive results for expanding and differentiating adipose-derived stem cells.

Micronic Celebrates 30 Years in Sample Storage
Friday, April 25, 2014
New product range catalogue published by Micronic.

New Approach to Temperature Control in Cell Therapy Clinical Trial
Wednesday, April 23, 2014
CoolCell® cell freezing device and CoolBox™ ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.

Advancing High-Content Analysis for Cancer Applications
Tuesday, April 08, 2014
A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research.

Tempo Bioscience Launches Human Cellular and Biosensor Products
Tuesday, April 08, 2014
Tempo Bioscience Inc announces the launch of its central nervous system (CNS) product line of human cell types for in vitro research and development (R&D) and chemical testing.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 521
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!